Tumor potential in rat wounds after short- and long-term administration of platelet-rich plasma: an update

E. Spartalis, D.I. Tsilimigras, I. Ntanasis-Stathopoulos, M. Spartalis, D. Moris

Article ID: 5258
Vol 32, Issue 5, 2018
DOI: https://doi.org/10.54517/jbrha5258
Received: 8 November 2018; Accepted: 8 November 2018; Available online: 8 November 2018; Issue release: 8 November 2018

Abstract

Comment on: Omar NN, et al. Tumor potential in rat wounds after short- and long-term administration of platelet-rich plasma. J Biol Regul Homeost Agents. 2017 Oct-Dec;31(4):889-899. Platelet-Rich Plasma (PRP) is a promising concentrate. But are there any disadvantages or contraindications regarding its application? Is the use of PRP indicated in wounds of patients undergoing resection for cancer. The presence of growth factors could promote tumor proliferation and recurrence. It is of the utmost importance to recognize any possible contraindication before we call it safe. The role of PRP in tumorigenicity deserves further experimental investigation and large-scale prospective randomized clinical trials.


Keywords

platelet-rich plasma;cancer;recurrence;safety


References

Supporting Agencies



Copyright (c) 2018 E. Spartalis, D.I. Tsilimigras, I. Ntanasis-Stathopoulos, M. Spartalis, D. Moris




This site is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).